Literature DB >> 27398383

Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study.

Steven G Morgan1, Jordan Hunt1, Jocelyn Rioux1, Jeffery Proulx1, Deirdre Weymann1, Cara Tannenbaum1.   

Abstract

BACKGROUND: Many medications pose greater health risks when prescribed for older adults, compared with available pharmacologic and nonpharmacologic alternatives. We sought to quantify the frequency and cost of potentially inappropriate prescribing for older women and men in Canada.
METHODS: Using data for 2013 from the National Prescription Drug Utilization Information System database, which contains prescription claims from publicly financed drug plans in all provinces except for Quebec, we identified the frequency of prescribing and cost of potentially inappropriate medications dispensed to provincial drug plan enrollees aged 65 years or more. Potentially inappropriate prescriptions were defined with the use of the American Geriatrics Society's 2012 version of the Beers Criteria for potentially inappropriate medication use in older adults.
RESULTS: For the 6 provinces with relatively complete data coverage (British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Prince Edward Island), 37% of older people filled 1 or more prescription meeting the Beers Criteria. A higher proportion of women (42%) than men (31%) filled potentially inappropriate prescriptions. The highest rates of prescribing of potentially inappropriate medications were among women aged 85 or more (47%). Benzodiazepines and other hypnotics were the leading contributors to the overall frequency of and sex differences in prescribing of potentially inappropriate drugs among older adults. We estimated that $75 per older Canadian, or $419 million in total, was spent on potentially inappropriate medications outside of hospital settings in 2013.
INTERPRETATION: Prescribing of potentially inappropriate medications for older adults is common and costly in Canada, especially for women. Multipronged and well-coordinated strategies to reduce the use and cost of potentially inappropriate drugs would likely generate significant health system savings while simultaneously generating major benefits to patient health.

Entities:  

Year:  2016        PMID: 27398383      PMCID: PMC4933607          DOI: 10.9778/cmajo.20150131

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  12 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

2.  Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.

Authors:  Jamie R Daw; Steven G Morgan
Journal:  Health Policy       Date:  2011-10-05       Impact factor: 2.980

3.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

4.  Engaging physicians and patients in conversations about unnecessary tests and procedures: Choosing Wisely Canada.

Authors:  Wendy Levinson; Tai Huynh
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

5.  Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.

Authors:  Cara Tannenbaum; Vakaramoko Diaby; Dharmender Singh; Sylvie Perreault; Mireille Luc; Helen-Maria Vasiliadis
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

6.  Potentially inappropriate prescribing and cost outcomes for older people: a national population study.

Authors:  Caitriona Cahir; Tom Fahey; Mary Teeling; Conor Teljeur; John Feely; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 7.  Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact.

Authors:  B Hill-Taylor; I Sketris; J Hayden; S Byrne; D O'Sullivan; R Christie
Journal:  J Clin Pharm Ther       Date:  2013-04-02       Impact factor: 2.512

8.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

Review 9.  Inappropriate medication use among the elderly: a systematic review of administrative databases.

Authors:  Lusiele Guaraldo; Fabíola G Cano; Glauciene S Damasceno; Suely Rozenfeld
Journal:  BMC Geriatr       Date:  2011-11-30       Impact factor: 3.921

Review 10.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.

Authors:  Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher
Journal:  Age Ageing       Date:  2014-10-16       Impact factor: 10.668

View more
  31 in total

1.  Implementing the Med Wise Program in rural Alberta: A feasibility study to support seniors.

Authors:  Heba A T Aref; Linda Kolewaski; Kyle Y Whitfield; Cheryl A Sadowski; Lisa M Guirguis
Journal:  Can Pharm J (Ott)       Date:  2021-02-15

2.  Canadian list of essential medications: Potential and uncertainties.

Authors:  Navindra Persaud; Haroon Ahmad
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

3.  Patient-Oriented Policies To Reduce The Harmful Effects Of Medication On Seniors' Brain Function.

Authors:  Lori A Daiello; Cara Tannenbaum
Journal:  Public Policy Aging Rep       Date:  2018-09-28

4.  Prevalence and factors associated with potentially inappropriate medication use in older medicare beneficiaries with cancer.

Authors:  Xue Feng; Gerald M Higa; Fnu Safarudin; Usha Sambamoorthi; Jongwha Chang
Journal:  Res Social Adm Pharm       Date:  2019-12-26

5.  Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals.

Authors:  Natasha Parekh; Yael Schenker; Chester B Good; Lynn Neilson; William H Shrank
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

6.  Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease.

Authors:  Andrew A Swanner; Chelsea E Hawley; Kay Li; Laura K Triantafylidis; Jiahua Li; Julie M Paik
Journal:  Clin Diabetes       Date:  2022-04-15

Review 7.  Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review.

Authors:  Ian A Scott; Peter I Pillans; Michael Barras; Christopher Morris
Journal:  Ther Adv Drug Saf       Date:  2018-07-12

8.  A prototype for evidence-based pharmaceutical opinions to promote physician-pharmacist communication around deprescribing.

Authors:  Philippe Martin; Cara Tannenbaum
Journal:  Can Pharm J (Ott)       Date:  2018-02-08

9.  Physician Financial Incentives to Reduce Unplanned Hospital Readmissions: an Interrupted Time Series Analysis.

Authors:  John A Staples; Guiping Liu; Jeffrey R Brubacher; Ahmer Karimuddin; Jason M Sutherland
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 5.128

10.  Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting.

Authors:  Kevin Migliazza; Caroline Bähler; Daniel Liedtke; Andri Signorell; Stefan Boes; Eva Blozik
Journal:  BMC Health Serv Res       Date:  2021-05-28       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.